ABUS vs TEL
Arbutus Biopharma Corp (ABUS) versus TE Connectivity Ltd (TEL) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
TE Connectivity Ltd (TEL) is a electronic components company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported TEL revenue for 2025-09-26 was $17.26B. Net income was $1.84B. Revenue was up 8.9% from 2024-09-27 to 2025-09-26. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. TEL currently screens at market cap $52.52B and trailing P/E 38.5.
Not investment advice. Open the ABUS and TEL stock pages for the full models.
Not investment advice.